In addition, downregulation of TRIM10 promoted the transcriptional activity of NF-κB in AML cells, whereas overexpression of TRIM10 suppressed the activation of NF-κB in AML cells. This evidence concerns the gene NFKB1 and acute myeloid leukemia.